Wiley Bros. Aintree Capital, LLC Bio Rad Laboratories, Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $12.5 Billion
- Q2 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 2,225 shares of BIO stock, worth $623,645. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,225
Previous 1,860
19.62%
Holding current value
$623,645
Previous $453,000
18.32%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BIO
# of Institutions
428Shares Held
19.1MCall Options Held
10.7KPut Options Held
35.5K-
First Eagle Investment Management, LLC2.52MShares$706 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$518 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$435 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$280 Million0.06% of portfolio
-
Veritas Asset Management LLP863KShares$242 Million2.27% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.9B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...